Encysive Wins Dismissal Of Securities Suit
A federal judge has dismissed a proposed class action lawsuit that accused Encysive Pharmaceuticals Inc. of misleading investors about the prospects for its pulmonary arterial hypertension treatment Thelin....To view the full article, register now.
Already a subscriber? Click here to view full article